<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="https://ri.ufs.br/jspui/handle/riufs/2459">
    <title>DSpace Coleção:</title>
    <link>https://ri.ufs.br/jspui/handle/riufs/2459</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="https://ri.ufs.br/jspui/handle/riufs/25793" />
        <rdf:li rdf:resource="https://ri.ufs.br/jspui/handle/riufs/25368" />
        <rdf:li rdf:resource="https://ri.ufs.br/jspui/handle/riufs/25298" />
        <rdf:li rdf:resource="https://ri.ufs.br/jspui/handle/riufs/25286" />
      </rdf:Seq>
    </items>
    <dc:date>2026-08-27T07:57:47Z</dc:date>
  </channel>
  <item rdf:about="https://ri.ufs.br/jspui/handle/riufs/25793">
    <title>Limiar glicêmico durante teste muscular inspiratório incremental em indivíduos saudáveis e com doença pulmonar obstrutiva crônica</title>
    <link>https://ri.ufs.br/jspui/handle/riufs/25793</link>
    <description>Título: Limiar glicêmico durante teste muscular inspiratório incremental em indivíduos saudáveis e com doença pulmonar obstrutiva crônica
Autor(es): Silva, Wasly Santana
Abstract: Introduction: The glycemic threshold (GT) during the incremental inspiratory muscle test&#xD;
(IIMT) has been proposed by our research group as a tool for inspiratory muscle functional&#xD;
assessment and individualized inspiratory muscle training (IMT) prescription. However, its&#xD;
agreement with the first lactate threshold (LT1) and its applicability in individuals with chronic&#xD;
obstructive pulmonary disease (COPD) have not yet been investigated. Objectives: To evaluate&#xD;
the agreement between GT and LT1 during the IIMT in healthy individuals and to investigate&#xD;
the determination of GT in individuals with COPD, as well as its associations with clinical and&#xD;
functional variables. Methods: Two studies were conducted using the IIMT. In the first study,&#xD;
healthy individuals performed the IIMT with simultaneous determination of GT, LT1, and the&#xD;
second lactate threshold (LT2). In the second study, individuals with COPD performed the&#xD;
IIMT for GT determination and analysis of its association with rating of perceived exertion,&#xD;
dyspnea, functional capacity, and cardiovascular autonomic balance. The incremental protocol&#xD;
started at 10% of the S-Index, with progressive workload increments until the point of&#xD;
exhaustion (PE). Results: In the first study, GT showed good agreement with LT1. LT1 and&#xD;
GT occurred at 22±8.3% and 26±13.2% of the S-Index, respectively, whereas LT2 and PE were&#xD;
identified at 44±10.1% and 60±14.1% of the S-Index. Bland–Altman analysis demonstrated&#xD;
low bias between methods for relative workload (−3.84±10.44% of the S-Index) and no&#xD;
proportional bias (p=0.06; R²=0.25). In the second study, GT was identified at 25±11.6% of the&#xD;
S-Index and showed a strong correlation with rating of perceived exertion during the IIMT&#xD;
(r=0.84; p&lt;0.01). In addition, PE and ΔGT–PE were correlated with cardiovascular autonomic&#xD;
balance (LF/HF: r=−0.83 and r=−0.71; p&lt;0.01), whereas ΔGT–PE was also correlated with&#xD;
dyspnea assessed by the modified Medical Research Council (mMRC) scale (r=−0.68; p=0.01)&#xD;
and Borg dyspnea at the end of the six-minute walk test (r=−0.83; p&lt;0.01). Conclusion: GT is&#xD;
an identifiable physiological marker during the IIMT, showing agreement with LT1 in healthy&#xD;
individuals and association with important clinical and functional variables in individuals with&#xD;
COPD. These findings support its potential as a tool for inspiratory muscle functional&#xD;
assessment and individualized IMT prescription.</description>
    <dc:date>2026-07-29T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://ri.ufs.br/jspui/handle/riufs/25368">
    <title>Efeito citotóxico do derivado indólico NM-01-28-22 em linhagem de carcinoma de pulmão</title>
    <link>https://ri.ufs.br/jspui/handle/riufs/25368</link>
    <description>Título: Efeito citotóxico do derivado indólico NM-01-28-22 em linhagem de carcinoma de pulmão
Autor(es): Melo, Marcos Vinícius Barbosa de
Abstract: Lung cancer is a neoplasm with a high mortality and incidence rate. The main&#xD;
treatments for lung cancer are chemotherapy, radiotherapy, and surgery, depending on&#xD;
the stage of the cancer in the patient. Chemotherapy is the most widely used therapeutic&#xD;
practice, but it has limitations due to adverse effects caused by its low systemic&#xD;
selectivity for normal cells compared to tumor cells. Many studies have demonstrated&#xD;
the importance of indoles and their derivatives in cancer research. Thus, indole and its&#xD;
derivatives allow for greater selectivity for tumor cells. Our study aims to evaluate the&#xD;
indole derivative NM-01-28-22 in cell inhibition in tumor cell lines and its cytotoxic&#xD;
effect on the lung carcinoma cell line. Initially, the compound was tested against cell&#xD;
lines to determine the most susceptible to the derivative. For this purpose, the&#xD;
Sulforhodamine B assay was used to evaluate the degree of inhibition of the&#xD;
NM-01-28-22 derivative in the three cell lines A549 (lung cancer), PC-3 (prostate&#xD;
cancer), and MCF-7 (breast cancer). For cytotoxicity assays in the A549 cell line, cell&#xD;
migration, clone formation, morphological alterations by DAPI and Phalloidin-Fitc&#xD;
staining, mitochondrial membrane potential by rhodamine 123 dye, and ROS production&#xD;
by the DCFH-DA probe were performed. Toxicity in human erythrocytes was verified&#xD;
by the hemolysis assay. In the analysis of the degree of inhibition, the values of the 50%&#xD;
inhibitory concentration (IC50) of the compound were obtained in the A549 (6.5 µM),&#xD;
MCF-7 (17.5 µM), and PC-3 (16.2 µM) cell lines. Given that the indolic derivative&#xD;
showed a low IC50 in A549 cells and considering its relevance in epidemiology, this&#xD;
cell line was used in subsequent cytotoxicity assays. The derivative inhibited cell&#xD;
migration and clone formation in A549 cells at all three concentrations. The derivative&#xD;
also induced loss of mitochondrial membrane potential and ROS production, suggesting&#xD;
cell death by apoptosis. The morphological changes evidenced by treatment with the&#xD;
derivative also show cell death in the A549 cell line. The derivative was tested at high&#xD;
concentrations in human erythrocytes and no toxic effect was observed. These results&#xD;
show that the derivative inhibited cell growth in three distinct tumor cell lines. It also&#xD;
showed a high cytotoxic effect in the A549 cell line without showing a toxic effect in&#xD;
human erythrocytes.</description>
    <dc:date>2026-02-13T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://ri.ufs.br/jspui/handle/riufs/25298">
    <title>Efeito gastroprotetor de isoflavonas em modelos experimentais de úlcera gástrica</title>
    <link>https://ri.ufs.br/jspui/handle/riufs/25298</link>
    <description>Título: Efeito gastroprotetor de isoflavonas em modelos experimentais de úlcera gástrica
Autor(es): Santos, Gideovania de Jesus
Abstract: Introduction: Peptic ulcers affect a significant portion of the world's population.&#xD;
Pharmacological treatment is mainly carried out with proton pump inhibitors and H2&#xD;
antagonists, which can cause significant adverse reactions. New therapeutic approaches&#xD;
are needed, given the adverse effects that current therapy brings to patients, in addition to&#xD;
the high number of disease recurrences. In this context, natural products stand out as&#xD;
sources of new molecules. Among these products, some studies highlight the potential&#xD;
impact of isoflavones in experimental models of gastric lesions. Objectives: To evaluate&#xD;
the scientific evidence on the therapeutic potential of isoflavones in preclinical models of&#xD;
gastric ulcer and the gastroprotective effect of daidzein in an acute model of gastric ulcer.&#xD;
Methods: The systematic review encompassed studies obtained through searches in Web&#xD;
of Science, ScienceDirect, Scopus, and MEDLINE/PubMed, which investigated the&#xD;
effects of isoflavones, tested in isolation, in models of gastric or duodenal ulcer in&#xD;
animals. The risk of bias was assessed using the SYRCLE platform tool. For the&#xD;
experimental study, male Swiss mice (25-35 g) were used. Gastric lesions were induced&#xD;
by acidified ethanol (60% ethanol/0.3 M HCl) in animals pre-treated with Daidzein (10,&#xD;
30, and 100 mg/kg, p.o.), vehicle (saline + 2% Tween 80), or standard drug (ranitidine&#xD;
100 mg/kg, p.o.) 60 minutes before induction. The control group (without ulcers) received&#xD;
water instead of acidified ethanol. After 60 min, the percentage of relative ulcerative&#xD;
lesion area (corrected for total stomach area) was measured. Results: Thirteen studies&#xD;
were included out of the 3005 identified with rodents, in models of ulcers induced by&#xD;
ethanol, acetic acid, indomethacin, or stress, in which isoflavones were tested in isolation.&#xD;
The results indicated important benefits associated with the administration of isoflavones,&#xD;
especially as a pretreatment. Most studies demonstrated the effects of genistein and&#xD;
formononetin, but studies with daidzein, osajine, pormiferin, and puerarin were also&#xD;
found. These studies associated the gastroprotective effects of these isoflavones mainly&#xD;
with their ability to reduce oxidative damage and positively regulate the activity of&#xD;
antioxidant enzymes, such as superoxide dismutase and catalase, and reduced glutathione&#xD;
concentrations. Another common characteristic observed in the studies was the reduction&#xD;
in the concentration of pro-inflammatory cytokines, mainly TNF-α and IL-1β, and&#xD;
myeloperoxidase activity. In the experimental study, it was observed that acidified ethanol&#xD;
caused ulcerative lesions (p&lt;0.01 vs. the group that received water) and that pretreatment&#xD;
with ranitidine, but not with daidzein doses, prevented the induction of ulcers (p&lt;0.01).&#xD;
Conclusion: From the review, it was possible to conclude that the studies provide&#xD;
evidence that isoflavones play a protective role against damage to the gastric mucosa&#xD;
caused by various aggressive agents, by producing anti-inflammatory and antioxidant&#xD;
responses. The literature supports the hypothesis that daidzein has a gastroprotective&#xD;
effect; however, its effects have only been investigated at very high doses. Therefore,&#xD;
there are no reports on its action at lower doses, which does not diminish the potential of&#xD;
the isoflavone class as gastroprotective agents.</description>
    <dc:date>2026-02-06T00:00:00Z</dc:date>
  </item>
  <item rdf:about="https://ri.ufs.br/jspui/handle/riufs/25286">
    <title>Análise da suplementação de creatina sobre o dano muscular e a performance em atletas do Powerlifting paralímpico</title>
    <link>https://ri.ufs.br/jspui/handle/riufs/25286</link>
    <description>Título: Análise da suplementação de creatina sobre o dano muscular e a performance em atletas do Powerlifting paralímpico
Autor(es): Paixão, Sarah Lisia da Silva
Abstract: Creatine monohydrate is the most widely used supplement in the sports field,&#xD;
aiming to improve performance, promote muscle mass gain, and reduce fatigue.&#xD;
It may also exert a protective effect against muscle damage induced by highintensity training. The present study aimed to analyze the short-term effects of&#xD;
creatine supplementation on dynamic strength indicators, muscle temperature,&#xD;
and biomarkers of muscle damage at pre-training, immediately post-training, and&#xD;
24 h and 48 h after exercise.&#xD;
This is a single-blind crossover study in which participants underwent an upperlimb resistance training program in two experimental conditions: creatine&#xD;
supplementation (20 g/day for seven days) and placebo, both prepared with&#xD;
identical color and flavor. The results indicated that, during exercises performed&#xD;
with a load of 45% of 1RM, creatine supplementation did not promote significant&#xD;
effects on the analyzed variables. In contrast, during training performed at 80%&#xD;
of 1RM, significant effects were observed, particularly for mean propulsive&#xD;
velocity (MPV) and maximal velocity (Vmax), especially in set 2 (MPV: p = 0.013;&#xD;
Vmax: p = 0.023) and set 5 (MPV: p = 0.017).&#xD;
In the analysis of muscle temperature, a significant increase was observed in the&#xD;
pectoralis muscle (clavicular portion) immediately after training (p = 0.049) and&#xD;
after 48 hours (p = 0.038), as well as in the triceps muscle after 24 hours (p =&#xD;
0.025) and 48 hours (p = 0.022) with supplementation. Regarding tissue damage&#xD;
biomarkers, creatine kinase did not show relevant changes, whereas lactate&#xD;
dehydrogenase presented differences when comparing the placebo group with&#xD;
the supplementation group at the following time points: pre-training (p &lt; 0.001),&#xD;
immediately post-training (p = 0.0007), 24 h post-training (p &lt; 0.001), and 48 h&#xD;
post-training (p &lt; 0.008), suggesting a protective effect of creatine against&#xD;
muscle damage. Significant differences were also observed for aspartate&#xD;
aminotransferase immediately post-training (p = 0.028) and alanine&#xD;
aminotransferase at the pre-training moment (p = 0.048).&#xD;
It can be concluded that creatine supplementation is effective in improving&#xD;
muscle performance, promoting gains in strength and power, and contributing to&#xD;
the prevention of potential injuries, especially when associated with high-intensity&#xD;
exercise.</description>
    <dc:date>2026-02-24T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

